Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #385095 on Innovation Pharmaceuticals Inc (IPIX)
Hugon
11/23/21 11:08 AM
#385111 RE: kfcyahoo #385095
CallMeCrazy
11/23/21 11:16 AM
#385113 RE: kfcyahoo #385095
Kevetrin died years ago. Ask the two patients(total patients enrolled) in the last , and only, phase 2 trial of that “ wonder drug.
Throughout pre-clinical testing and two successful clinical trials, Kevetrin has demonstrated promising signs of efficacy as an anti-cancer agent and a favorable pharmacokinetic profile that includes a very short half-life and good bioavailability. It is believed that these characteristics make Kevetrin an ideal candidate for oral delivery (capsule or tablet), which will facilitate convenient and frequent dosing, perhaps even multiple times daily, to maximize the therapeutic benefit of the compound.